Engineering a Safe, Quality and Patient-Centric Device
Support Your Emerging Biologics Portfolio through Injectable Device by Streamlining Your Device Development, Exploring New Platforms and Mitigating Risks
The Digital Injectables Summit will celebrate the 10th anniversary this September - gathering 100+ senior device leaders to share their latest innovations from pre-filled syringes to autoinjectors, in order to better serve patients worldwide.
As advanced therapies and novel formulations are emerging, device leaders racing against the clock to design and develop the next best injectable device for timely launch, while not compromising on usability and human factors studies.
We are aspired to help the community improve engineering excellence, with the 2020 agenda focusing on:
- Streamlining device development timeline and leverage strategic platforming
- From usability testing to primary packaging - what is required from an engineering perspective for a new injectable device
- Primary container innovation to support high volume, high viscosity delivery
- The impacts of EU MDR and FDA's reliability testing requirement for a quality injectable device
- The reality of a connected injectable device for advanced medicinal therapeutic products
Take a look at your comprehensive event guide to find out more.
Pharma, Biotechs and Academics - Free to attend. Solution Providers not included.: USD 0.0
Speakers: Paul Roussel Senior Director - Combination Products Kiniksa Pharmaceuticals, Daniel Latham Head of Device Development and LCM Novartis, John Schalago Executive Director, Senior GPRD Novartis, Tycho Speaker Director, Drug Delivery and Biomaterials Allergan, Stephen Gilmore Director of Engineering Crux Product Design, Michael Song Head of Device Functionality, Safety, Digital Connectivity AstraZeneca, Alasdair Young Director, Device Engineering Coherus Biosciences, Tracy Hsu Associate Director Ionis Pharmaceuticals, Ophelia Wells Device Development Project Lead Merck, James Birchall Deputy Head of School Cardiff University, Min Wei Former Associate Director Janssen, Prem Ganapathy Head of Device Testing Takeda, Young Chun Associate Director, Human Factors and User Research Takeda, Prasad Peri Senior Director, Regulatory Affairs and CMC Teva Pharmaceuticals, Richard Featherstone Research Director - Human Factors Research and Design Emergo by UL, Murat Gunay Senior Consultant Engineer, Delivery and Device R and D Eli Lilly, Alex Weaver Director of Engineering PCI Pharma Services, Adam Schroeder Business Development Manager PCI Pharma Services, Alan Golden Principal Design Quality Consultants, LLC, Joely Gardner, PhD Professor; Chief Researcher California State Fullerton; Human Factors Research, Sion Coulman Senior Lecturer Cardiff University
Time: 2:00 pm to 10:00 pm